Back
Cara Therapeutics Stock Predictions
Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
CARA
Cara Therapeutics
Last Price:
$5.36
Seasonality Move:
-8.29%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Cara Therapeutics Stock Forecast
-
Over the next 52 weeks, Cara Therapeutics has on average historically fallen by 5.8% based on the past 11 years of stock performance.
-
Cara Therapeutics has fallen lower in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
-
Is Cara Therapeutics Stock Undervalued?The current Cara Therapeutics [CARA] share price is $5.15. The Score for CARA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CARA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cara Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Cara Therapeutics has on average historically fallen by 5.8% based on the past 11 years of stock performance.
Cara Therapeutics Stock Rating
Sell
36
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics overpriced?
-
Cara Therapeutics has fallen lower in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
Cara Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
caratherapeutics.com
52-Week Data
52-Week High:
11.52
52-Week Low:
2.71
Prediction Charts
Market Cap:
23.6M
Price in USD:
5.15
Volume:
7.7K
Beta:
1.05
Technical Analysis
SMA50:
4.97
SMA100:
4.40
SMA200:
4.27
52-Wk Change:
-52.46%
Stock Predictions
-
Is Cara Therapeutics stock public?Yes, Cara Therapeutics is a publicly traded company.
-
What is the Cara Therapeutics stock quote today?The Cara Therapeutics stock price is 5.15 USD today.
-
How to buy Cara Therapeutics stock online?You can buy Cara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-28 | 4.75 | 4.86 | 5.00 | 4.64 |
| Mar-3 | 4.69 | 4.63 | 4.89 | 4.62 |
| Mar-4 | 4.62 | 4.43 | 4.62 | 4.30 |
| Mar-5 | 4.30 | 4.50 | 4.66 | 4.30 |
| Mar-6 | 4.44 | 4.84 | 4.84 | 4.44 |
| Mar-7 | 4.87 | 4.92 | 4.95 | 4.86 |
| Mar-11 | 5.00 | 5.13 | 5.20 | 4.87 |
| Mar-12 | 5.20 | 5.11 | 5.20 | 4.99 |
| Mar-13 | 5.16 | 5.06 | 5.20 | 5.00 |
| Mar-14 | 5.06 | 5.13 | 5.13 | 5.00 |
| Mar-17 | 5.07 | 5.12 | 5.20 | 5.03 |
| Mar-18 | 5.03 | 5.20 | 5.25 | 5.03 |
| Mar-19 | 5.29 | 5.23 | 5.29 | 5.09 |
| Mar-20 | 5.20 | 5.15 | 5.20 | 5.07 |
Cara Therapeutics Earnings
Cara Therapeutics Earnings Report: Per Share Cara Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cara Therapeutics Forecast Revenue Growth
Cara Therapeutics Stock Analysis: Historical quarterly revenues per share for Cara Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.